Global Markets and Technologies for Advanced Drug Delivery Systems
January 1, 2021
BCC Research
243
PDF
Global Markets and Technologies for Advanced Drug Delivery Systems
Abstract Report Highlights The global market for advanced drug delivery systems should grow from $231.0 billion in 2020 to $310.0 billion by 2025, at a compound annual growth rate (CAGR) of 6.1% for the period of 2020-2025.
Report Includes 62 data tables 62 additional tables An overview of the global markets and technologies for advanced drug delivery systems Analyses of global market trends, with data from 2018, 2019, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025 A look into the current state, setbacks, innovations, and future trends, and coverage of clinical trials in drug delivery systems Discussion on the different categories of drug delivery, and details of acquisitions, mergers, and alliances by companies and global organizations Description of advanced immediate-release technology and delayed release and pulsatile release drug delivery technology Information on monoclonal antibodies (MAbs), Prodrugs and other drug carriers of advanced drug delivery systems Insights of the regulatory environment, and the technology involved, including the latest trends and developments Company profiles of major players including Alcon, Bausch & Lomb, Baxter International Inc., Eisai Co. Ltd., GlaxoSmithKline PLC, Eli Lilly, Novartis and Sanofi
Report Scope This report represents a current and important business tool to evaluate technologies, trends, products and market participants in the advanced drug delivery sector. The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different types of industries.
Content Chapter- 1: Introduction 3 Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources and Methodology Intended Audience Analyst's Credentials BCC Custom Research Related BCC Research Reports Chapter- 2: Summary and Highlights 2 $250 Table Summary : Global Market for Advanced Drug Delivery Systems, by Region, Through 2025 Figure Summary : Global Market for Advanced Drug Delivery Systems, by Region, 2018-2025 Chapter- 3: Evaluation of the Market Based on Technology 46 $1,041 Overview of Advanced Drug Delivery Systems and Technologies Summary of the Market for Advanced Drug Delivery Systems Based on Drug Release Mechanism Chapter- 4: Evaluation of the Market Based on Route of Administration 57 $1,290 Overview of Advanced Drug Delivery Systems and Route of Administration Summary of the Market for Advanced Drug Delivery Systems Based on Route of Administration Chapter- 5: Evaluation of the Market Based on Vehicle/Carrier 38 $860 Overview of Advanced Drug Delivery Systems and Vehicles/Carriers Summary of the Market for Advanced Drug Delivery Systems Based on Drug Delivery Vehicle/Carrier Chapter- 6: Evaluation of the Market Based on Application 38 $860 Overview of Advanced Drug Delivery Systems and Applications Applications Summary of the Market for Advanced Drug Delivery Systems Based on Application Chapter- 7: Evaluation of the Market Based on Geographic Region 5 $113 Overview of the Geographical Distribution of the Market for Advanced Drug Delivery Systems Summary of the Market for Advanced Drug Delivery Systems by Region Chapter- 8: Overview of the Advanced Medical Device Industry 6 $136 Mergers and Acquisitions (M&A) Trends in Clinical Trials on Drug Delivery Systems Chapter- 9: Review of Patents on Advanced Drug Delivery Systems 18 $407 Table 110 : Patents and Patent Applications Worldwide on Drug Delivery Release Mechanisms Table 111 : Examples of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms Table 112 : Patents and Patent Applications Worldwide on Drug Delivery and Route of Administration Technologies Table 113 : Examples of Patents and Patent Applications Filed on Drug Delivery and Route of Administration Technologies Table 114 : Patents and Patent Applications Worldwide on Drug Delivery Applications Table 115 : Examples of Patents and Patent Applications Filed on Drug Delivery Applications Table 116 : Search Analysis for Patents and Patent Applications Worldwide Using Keyword Combinations on Drug Delivery Carriers Table 117 : Examples of Patents and Patent Applications Filed on Drug Delivery Carriers Table 118 : Number of Patents and Patent Applications, by Company Table 119 : Examples of Patents and Patent Applications Filed on Drug Delivery, by Different Companies Chapter- 10: Market Summary 11 $249 Overview of the Market for Advanced Drug Delivery Systems Market Drivers and Restraints Market Estimates and Analysis Chapter- 11: Company Profiles 19 $430 ABBOTT LABORATORIES ADARE PHARMACEUTICALS ALCON INC. ALKERMES AMGEN INC. ASTRAZENECA PLC BAUSCH & LOMB BAXTER INTERNATIONAL INC. BAYER HEALTHCARE PHARMACEUTICALS BIOGEN IDEC BOEHRINGER INGELHEIM BOSTON SCIENTIFIC BRISTOL-MYERS SQUIBB CAPSUGEL (LONZA) CATALENT CURE PHARMACEUTICAL EISAI CO., LTD. ENZON PHARMACEUTICALS GENENTECH INC. (ROCHE) GENEREX BIOTECHNOLOGY CORP. GILEAD SCIENCES INC. GLAXOSMITHKLINE PLC HISAMITSU PHARMACEUTICAL CO. INC. ELI LILLY AND CO. JANSSEN BIOTECH INC. JOHNSON & JOHNSON KEMPHARM INC. MANNKIND CORP. MERCK & CO. MYLAN LABORATORIES INC. NEKTAR THERAPEUTICS NOVARTIS AG NOVAVAX INC. NOVEN PHARMACEUTICALS PFIZER INC. ROCHE HOLDING AG SANOFI SA TEVA PHARMACEUTICAL INDUSTRIES LTD. XEL PHARMACEUTICALS
Report Highlights The global market for advanced drug delivery systems should grow from $231.0 billion in 2020 to $310.0 billion by 2025, at a compound annual growth rate (CAGR) of 6.1% for the period of 2020-2025.
Report Includes 62 data tables 62 additional tables An overview of the global markets and technologies for advanced drug delivery systems Analyses of global market trends, with data from 2018, 2019, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025 A look into the current state, setbacks, innovations, and future trends, and coverage of clinical trials in drug delivery systems Discussion on the different categories of drug delivery, and details of acquisitions, mergers, and alliances by companies and global organizations Description of advanced immediate-release technology and delayed release and pulsatile release drug delivery technology Information on monoclonal antibodies (MAbs), Prodrugs and other drug carriers of advanced drug delivery systems Insights of the regulatory environment, and the technology involved, including the latest trends and developments Company profiles of major players including Alcon, Bausch & Lomb, Baxter International Inc., Eisai Co. Ltd., GlaxoSmithKline PLC, Eli Lilly, Novartis and Sanofi
Report Scope This report represents a current and important business tool to evaluate technologies, trends, products and market participants in the advanced drug delivery sector. The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different types of industries.
Chapter- 1: Introduction 3 Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources and Methodology Intended Audience Analyst's Credentials BCC Custom Research Related BCC Research Reports Chapter- 2: Summary and Highlights 2 $250 Table Summary : Global Market for Advanced Drug Delivery Systems, by Region, Through 2025 Figure Summary : Global Market for Advanced Drug Delivery Systems, by Region, 2018-2025 Chapter- 3: Evaluation of the Market Based on Technology 46 $1,041 Overview of Advanced Drug Delivery Systems and Technologies Summary of the Market for Advanced Drug Delivery Systems Based on Drug Release Mechanism Chapter- 4: Evaluation of the Market Based on Route of Administration 57 $1,290 Overview of Advanced Drug Delivery Systems and Route of Administration Summary of the Market for Advanced Drug Delivery Systems Based on Route of Administration Chapter- 5: Evaluation of the Market Based on Vehicle/Carrier 38 $860 Overview of Advanced Drug Delivery Systems and Vehicles/Carriers Summary of the Market for Advanced Drug Delivery Systems Based on Drug Delivery Vehicle/Carrier Chapter- 6: Evaluation of the Market Based on Application 38 $860 Overview of Advanced Drug Delivery Systems and Applications Applications Summary of the Market for Advanced Drug Delivery Systems Based on Application Chapter- 7: Evaluation of the Market Based on Geographic Region 5 $113 Overview of the Geographical Distribution of the Market for Advanced Drug Delivery Systems Summary of the Market for Advanced Drug Delivery Systems by Region Chapter- 8: Overview of the Advanced Medical Device Industry 6 $136 Mergers and Acquisitions (M&A) Trends in Clinical Trials on Drug Delivery Systems Chapter- 9: Review of Patents on Advanced Drug Delivery Systems 18 $407 Table 110 : Patents and Patent Applications Worldwide on Drug Delivery Release Mechanisms Table 111 : Examples of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms Table 112 : Patents and Patent Applications Worldwide on Drug Delivery and Route of Administration Technologies Table 113 : Examples of Patents and Patent Applications Filed on Drug Delivery and Route of Administration Technologies Table 114 : Patents and Patent Applications Worldwide on Drug Delivery Applications Table 115 : Examples of Patents and Patent Applications Filed on Drug Delivery Applications Table 116 : Search Analysis for Patents and Patent Applications Worldwide Using Keyword Combinations on Drug Delivery Carriers Table 117 : Examples of Patents and Patent Applications Filed on Drug Delivery Carriers Table 118 : Number of Patents and Patent Applications, by Company Table 119 : Examples of Patents and Patent Applications Filed on Drug Delivery, by Different Companies Chapter- 10: Market Summary 11 $249 Overview of the Market for Advanced Drug Delivery Systems Market Drivers and Restraints Market Estimates and Analysis Chapter- 11: Company Profiles 19 $430 ABBOTT LABORATORIES ADARE PHARMACEUTICALS ALCON INC. ALKERMES AMGEN INC. ASTRAZENECA PLC BAUSCH & LOMB BAXTER INTERNATIONAL INC. BAYER HEALTHCARE PHARMACEUTICALS BIOGEN IDEC BOEHRINGER INGELHEIM BOSTON SCIENTIFIC BRISTOL-MYERS SQUIBB CAPSUGEL (LONZA) CATALENT CURE PHARMACEUTICAL EISAI CO., LTD. ENZON PHARMACEUTICALS GENENTECH INC. (ROCHE) GENEREX BIOTECHNOLOGY CORP. GILEAD SCIENCES INC. GLAXOSMITHKLINE PLC HISAMITSU PHARMACEUTICAL CO. INC. ELI LILLY AND CO. JANSSEN BIOTECH INC. JOHNSON & JOHNSON KEMPHARM INC. MANNKIND CORP. MERCK & CO. MYLAN LABORATORIES INC. NEKTAR THERAPEUTICS NOVARTIS AG NOVAVAX INC. NOVEN PHARMACEUTICALS PFIZER INC. ROCHE HOLDING AG SANOFI SA TEVA PHARMACEUTICAL INDUSTRIES LTD. XEL PHARMACEUTICALS